Welcome to BioMarket Group!

The Cardiovascular Market Outlook to 2009

Additional Information

Published Date Oct 1, 2004
Special Offer No
Pages 142
PDF Fact Sheet View Fact Sheet for the report The Cardiovascular Market Outlook to 2009 in PDF format.
Published on Date No
Format No
Publisher Business Insights
Product Line No
Full Title No

Availability: In stock

$2,875.00

Quick Overview

Report which provides detailed analysis on the major cardiovascular therapy areas and assesses competitive dynamics over the period 2004 to 2009.
Request free sample pages from The Cardiovascular Market Outlook to 2009

Executive Summary

The Cardiovascular Market Outlook to 2009’ is a report which provides detailed analysis on the major cardiovascular therapy areas and assesses competitive dynamics over the period 2004 to 2009. This report provides essential data, analysis and forecasts allowing you to position your products effectively, maximize market opportunities and increase cardiovascular revenues. The cardiovascular market is set to undergo a period of radical change, as today’s blockbusters lose patent protection. The pharmaceutical industry is embracing innovative new technologies in order to provide the products of tomorrow, but with high costs and risks associated with the development of new medicines in this area, there will be fewer winners than losers in the future. Use this analysis to identify the forthcoming issues affecting cardiovascular markets, drugs, and companies and gain insight into the forces driving the most valuable sector of the pharmaceutical industry over the next 5 years.

Request free sample pages from The Cardiovascular Market Outlook to 2009

Other selected research from the 'Pharmacoeconomics' category:


Mobile Enterprise Solutions: Assessing the Market Opportunities for the Pharmaceutical Industry
The pharmaceutical industry, particularly in the US, has been an early adopter of mobile field sales solutions. Pharmaceutical companies have a significant portion of executives and employees that are mobile workers, prompting this earlier adoption. Pharma companies will need to align their investment in mobile enterprise solutions with the evolution of the enterprise mobile device market. Learn More


Medical Professional Websites: Building Relationships with Physicians Online
Medical professional websites allow pharmaceutical companies to increase competitiveness through the use of online channels to raise awareness of their products. By providing Internet-based opportunities for professional development, patient education materials and clinical tools, pharmaceutical companies can cost-effectively build relationships with a large number of medical professionals. Learn More

Other selected research from the 'Cardiovascular' category:


Commercial Insight: Antihypertensives - Two Years to Shape the Market?
Datamonitor expects the antihypertensive market to exceed $50bn by 2014 across the seven major markets, with novel treatments and the market-leading ARBs delivering much of this value. However, significant hurdles exist, and pharmaceutical companies need to be savvy regarding marketing and pricing structures for their products, as only the most cunning and aggressive companies look set to survive. Learn More


Stakeholder Opinions: Heart Failure - When drugs do not work
In-depth analysis on the latest trends and developments in non-pharmacological treatment of advanced heart failure. Learn More